Clinical implementation of targeted and immunotherapies for advanced RCC

Episode 1 December 14, 2022 00:19:51
Clinical implementation of targeted and immunotherapies for advanced RCC
COR2ED Medical Education
Clinical implementation of targeted and immunotherapies for advanced RCC

Dec 14 2022 | 00:19:51

/

Show Notes

Prof. Thomas Powles, a Medical Oncologist from Barts Cancer Centre in the UK and Dr Friederike Schlürmann a Medical Oncologist from University Hospital of Brest and Quimper in France, discuss the clinical implementation of targeted and immunotherapies for advanced renal cell carcinoma (RCC).

In this podcast, the two experts discuss data from key trials CHECKMATE 214 (ipilimumab and nivolumab), KEYNOTE 426 (axitinib and pembrolizumab), CHECKMATE 9ER (cabozantinib and nivolumab), CLEAR (Lenvatinib and pembrolizumab) and COSMIC 313 (cabozantinib plus nivolumab and ipilimumab) and the implications for clinical practice.

They also discuss management of toxicities associated with combination treatments, including dosing strategies to ensure the patient remains on optimal treatment and improved education for patients and clinicians so that they recognise side effects and how to manage them.

Other Episodes

Episode 1

January 16, 2023 00:19:18
Episode Cover

Gynaecological considerations in Women with Bleeding Disorders

COR2ED Medical Education: In this podcast, Dr Sarah O’Brien and Dr Homa Ahmadzia discuss gynaecological considerations in women and girls who have an underlying...

Listen

Episode 1

August 17, 2022 00:29:42
Episode Cover

Role of immunotherapy beyond advanced HCC

COR2ED Medical Education: In this podcast, liver cancer experts Prof. Amit Singal and Assoc. Prof Neil Mehta discuss recent advances in systemic and locoregional...

Listen

Episode 1

January 05, 2023 00:22:24
Episode Cover

SARCOMA updates from CTOS 2022

COR2ED Medical Education: In this podcast, Prof. Jonathan Trent and Prof. Robin Jones discuss what’s new in the patient management in sarcoma from CTOS...

Listen